Most drug discovery programmes now use functional, cell-based assays for target hit identification and lead optimisation because of the desire to utilise the scientific understanding of signalling pathways. This has resulted in a capability to probe more complex targets and seek target modulation, rather than complete inhibition.

Pharmaceutical companies have also employed stem cell technology for drug discovery and testing for more than 10 years. Stem cells may help us understand the complexity of human disease by studying cells as they become more differentiated, making nerves, skin, cartilage, bone and brain. Drug developers hope that............